Quibim, established in Valencia, is at the forefront of revolutionizing medical imaging through Artificial Intelligence. With an extensive team of over 90 specialists and more than 230 partner sites globally, Quibim leverages AI technology to enhance diagnostic accuracy and improve patient outcomes. The brand's flagship offerings include QP-Prostate®, QP-Brain®, QP-Liver®, QP-Breast®, and QP-Lung®, in addition to the innovative QP-Insights® platform.

These products transform complex imaging data from modalities like MRI, CT, and PET into actionable insights that support healthcare providers and life sciences. Quibim’s business model is centered around a Software as a Service (SaaS) platform that fosters value-based partnerships, enabling the development of new algorithms tailored to meet market demands. Launched internationally in 2021, Quibim is committed to ongoing research and innovation, with plans to introduce new predictive imaging biomarker panels that further enhance healthcare delivery.

Join Quibim in its mission to utilize AI for improving human health